Sera Prognostics (SERA) Liabilities and Shareholders Equity (2020 - 2026)
Sera Prognostics posted quarterly Liabilities and Shareholders Equity of $93.5 million for Q1 2026, down 20.85% year-on-year from $118.2 million in Q1 2025, and down 8.23% on a QoQ basis from $101.9 million in Q4 2025.
Sera Prognostics (SERA) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $93.5 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 20.85% year-over-year to $93.5 million; the trailing twelve-month figure through Mar 2026 stood at $415.4 million (up 17.15% YoY), and the FY2025 full-year result was $101.9 million, up 40.45% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $93.5 million, down from $101.9 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $134.9 million in Q1 2022 and bottomed at $72.6 million in Q4 2024.
- The 5-year median for Liabilities and Shareholders Equity is $101.9 million (2025), against an average of $102.4 million.
- The widest annual swing landed in 2022, when Liabilities and Shareholders Equity slipped 24.16%; it then soared 40.45% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $116.3 million in 2022, then decreased by 17.96% to $95.4 million in 2023, then decreased by 23.96% to $72.6 million in 2024, then soared by 40.45% to $101.9 million in 2025, then fell by 8.23% to $93.5 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $93.5 million (Q1 2026), $101.9 million (Q4 2025), and $108.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 | 93.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.54 Mn |
| Dec 31, 2025 | 101.93 Mn |
| Sep 30, 2025 | 108.13 Mn |
| Jun 30, 2025 | 111.83 Mn |
| Mar 31, 2025 | 118.18 Mn |
| Dec 31, 2024 | 72.58 Mn |
| Sep 30, 2024 | 79.00 Mn |
| Jun 30, 2024 | 84.86 Mn |
| Mar 31, 2024 | 89.89 Mn |
| Dec 31, 2023 | 95.44 Mn |
| Sep 30, 2023 | 90.06 Mn |
| Jun 30, 2023 | 96.68 Mn |
| Mar 31, 2023 | 105.61 Mn |
| Dec 31, 2022 | 116.33 Mn |
| Sep 30, 2022 | 116.56 Mn |
| Jun 30, 2022 | 125.06 Mn |
| Mar 31, 2022 | 134.87 Mn |
| Dec 31, 2021 | 147.03 Mn |
| Sep 30, 2021 | 153.69 Mn |
| Jun 30, 2021 | 95.07 Mn |
| Dec 31, 2020 | 14.80 Mn |